Since TfR1 is commonly expressed in the most cell types including heart, and the mutant DMPK is the central player in DM1 cardiomyopathy, the FORCE platform can deliver ASOs specifically to cardiac and skeletal muscle. Here, DMPK is linked to cardiomyopathy.